Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current Diabetes Reports
Published in: Current Diabetes Reports 9/2017

01-09-2017 | Hospital Management of Diabetes (A Wallia and JJ Seley, Section Editors)

How Low Can You Go? Reducing Rates of Hypoglycemia in the Non-critical Care Hospital Setting

Authors: Kristen Kulasa, Patricia Juang

Published in: Current Diabetes Reports | Issue 9/2017

Login to get access

Abstract

Purpose of Review

The purpose of this review is to discuss strategies to reduce rates of hypoglycemia in the non-critical care setting.

Recent Findings

Strategies to reduce hypoglycemia rates should focus on the most common causes of iatrogenic hypoglycemia. Creating a standardized insulin order set with built-in clinical decision support can help reduce rates of hypoglycemia. Coordination of blood glucose monitoring, meal tray delivery, and insulin administration is an important and challenging task. Protocols and processes should be in place to deal with interruptions in nutrition to minimize risk of hypoglycemia. A glucose management page that has all the pertinent information summarized in one page allows for active surveillance and quick identification of patients who may be at risk of hypoglycemia. Finally, education of prescribers, nurses, food and nutrition services, and patients is important so that every member of the healthcare team can work together to prevent hypoglycemia.

Summary

By implementing strategies to reduce hypoglycemia, we hope to lower rates of adverse events and improve quality of care while also reducing hospital costs. Future research should focus on the impact of an overall reduction in hypoglycemia to determine whether the expected benefits are achieved.
Literature
1.
Turchin A, Matheny ME, Shubina M, Scanlon JV, Greenwood B, Pendergrass ML. Hypoglycemia and clinical outcomes in patients with diabetes hospitalized in the general ward. Diabetes Care. 2009;32(7):1153–7.CrossRefPubMedPubMedCentral
2.
Garg R, Hurwitz S, Turchin A, Trivedi A. Hypoglycemia, with or without insulin therapy, is associated with increased mortality among hospitalized patients. Diabetes Care. 2013;36(5):1107–10.CrossRefPubMedPubMedCentral
3.
Brodovicz KG, Mehta V, Zhang Q, Zhao C, Davies MJ, Chen J, et al. Association between hypoglycemia and inpatient mortality and length of hospital stay in hospitalized, insulin-treated patients. Curr Med Res Opin. 2013;29(2):101–7.CrossRefPubMed
4.
Nirantharakumar K, Marshall T, Hodson J, Narendran P, Deeks J, Coleman JJ, et al. Hypoglycemia in non-diabetic in-patients: clinical or criminal? PLoS One. 2012;7(7):e40384.CrossRefPubMedPubMedCentral
5.
• Milligan PE, Bocox MC, Pratt E, Hoehner CM, Krettek JE, Dunagan WC. Multifaceted approach to reducing occurrence of severe hypoglycemia in a large healthcare system. Am J Health Syst Pharm. 2015;72(19):1631–41. This article provides a great example of how one hospital system was able to significantly reduce severe hypoglycemia across 11 hospitals using many of the approaches mentioned in this paper.CrossRefPubMed
6.
Finfer S, Chittock DR, Su SY, Blair D, Foster D, Dhingra V, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360(13):1283–97.CrossRefPubMed
7.
Classen DC, Jaser L, Budnitz DS. Adverse drug events among hospitalized Medicare patients: epidemiology and national estimates from a new approach to surveillance. Jt Comm J Qual Patient Saf. 2010;36(1):12–21.CrossRefPubMed
8.
Analytics) PATH, Analytics) WLTH, (AHRQ) SC. Costs for Hospital Stays in the United States Rockville, MD2011.
9.
Classen DC, Resar R, Griffin F, Federico F, Frankel T, Kimmel N, et al. ‘Global trigger tool’ shows that adverse events in hospitals may be ten times greater than previously measured. Health Aff (Millwood). 2011;30(4):581–9.CrossRef
10.
Moghissi ES, Korytkowski MT, DiNardo M, Einhorn D, Hellman R, Hirsch IB, et al. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Endocr Pract. 2009;15(4):353–69.CrossRefPubMed
11.
Curkendall SM, Natoli JL, Alexander CM, Nathanson BH, Haidar T, Dubois RW. Economic and clinical impact of inpatient diabetic hypoglycemia. Endocr Pract. 2009;15(4):302–12.CrossRefPubMed
12.
Carey M, Boucai L, Zonszein J. Impact of hypoglycemia in hospitalized patients. Curr Diab Rep. 2013;13(1):107–13.CrossRefPubMed
13.
Brutsaert E, Carey M, Zonszein J. The clinical impact of inpatient hypoglycemia. J Diabetes Complicat. 2014;28(4):565–72.CrossRefPubMed
14.
Varghese P, Gleason V, Sorokin R, Senholzi C, Jabbour S, Gottlieb JE. Hypoglycemia in hospitalized patients treated with antihyperglycemic agents. J Hosp Med. 2007;2(4):234–40.CrossRefPubMed
15.
Michota F, Braithwaite SS. Avoiding complications in the hospitalized patient: the case for tight glycemic control. J Hosp Med. 2007;2(Suppl 1):1–4.CrossRefPubMed
16.
Dendy JA, Chockalingam V, Tirumalasetty NN, Dornelles A, Blonde L, Bolton PM, et al. Identifying risk factors for severe hypoglycemia in hospitalized patients with diabetes. Endocr Pract. 2014;20(10):1051–6.CrossRefPubMed
17.
American Diabetes Association. Glycemic targets. Sec 6. In Standards of Medical Care in Diabetes—2017. Diabetes Care. 2017;40(Suppl. 1):S48–56.CrossRef
18.
Seaquist ER, Anderson J, Childs B, Cryer P, Dagogo-Jack S, Fish L, et al. Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society. Diabetes Care. 2013;36(5):1384–95.CrossRefPubMedPubMedCentral
19.
Cook CB, Elias B, Kongable GL, Potter DJ, Shepherd KM, McMahon D. Diabetes and hyperglycemia quality improvement efforts in hospitals in the United States: current status, practice variation, and barriers to implementation. Endocr Pract. 2010;16(2):219–30.CrossRefPubMed
20.
Goldberg PA, Bozzo JE, Thomas PG, Mesmer MM, Sakharova OV, Radford MJ, et al. “Glucometrics”—assessing the quality of inpatient glucose management. Diabetes Technol Ther. 2006;8(5):560–9.CrossRefPubMed
21.
Schnipper JL, Magee M, Larsen K, Inzucchi SE, Maynard G. Society of Hospital Medicine Glycemic Control Task Force summary: practical recommendations for assessing the impact of glycemic control efforts. J Hosp Med. 2008;3(5 Suppl):66–75.CrossRefPubMed
22.
Maynard GA, Childers D, Holdych J, Kendall H, Hoag T, Harrison K. Improving glycemic control safely in non-critical care patients: a collaborative systems approach in nine hospitals. Jt Comm J Qual Patient Saf. 2017;43(4):179–88.CrossRefPubMed
23.
24.
Boyd JC, Bruns DE. Quality specifications for glucose meters: assessment by simulation modeling of errors in insulin dose. Clin Chem. 2001;47(2):209–14.PubMed
25.
Blood glucose monitoring test systems for prescription point-of-care use: guidance for industry and food and drug administration staff [Internet]. 2016.
26.
Klonoff DC, Draznin B, Drincic A, Dungan K, Gianchandani R, Inzucchi SE, et al. PRIDE statement on the need for a moratorium on the CMS plan to cite hospitals for performing point-of-care capillary blood glucose monitoring on critically ill patients. J Clin Endocrinol Metab. 2015;100(10):3607–12.CrossRefPubMed
27.
Gomez AM, Umpierrez GE, Munoz OM, Herrera F, Rubio C, Aschner P, et al. Continuous glucose monitoring versus capillary point-of-care testing for inpatient glycemic control in type 2 diabetes patients hospitalized in the general ward and treated with a basal bolus insulin regimen. J Diabetes Sci Technol. 2015;10(2):325–9.CrossRefPubMedPubMedCentral
28.
Aloi J, Bode BW, Ullal J, Chidester P, McFarland RS, Bedingfield AE, et al. Comparison of an electronic glycemic management system versus provider-managed subcutaneous basal bolus insulin therapy in the hospital setting. J Diabetes Sci Technol. 2016;
29.
CMS/The Joint Commission. NQF-endorsed voluntary consensus standards for hospital care. Surgical care improvement project. 2014.
30.
Maynard G, Schnipper JL, Messler J, Ramos P, Kulasa K, Nolan A, et al. Design and implementation of a web-based reporting and benchmarking center for inpatient glucometrics. J Diabetes Sci Technol. 2014;8(4):630–40.CrossRefPubMedPubMedCentral
31.
Department of Health and Human Services. National Action Plan for Adverse Drug Event Prevention. 2014. [Available from: www.​health.​gov/​hai/​ pdfs/ADE-Action-Plan-508c.pdf.
32.
33.
Maynard G, Kulasa K, Ramos P, Childers D, Clay B, Sebasky M, et al. Impact of a hypoglycemia reduction bundle and a systems approach to inpatient glycemic management. Endocr Pract. 2015;21(4):355–67.CrossRefPubMed
34.
Sinha Gregory N, Seley JJ, Gerber LM, Tang C, Brillon D. Decreased rates of hypoglycemia following implementation of a comprehensive computerized insulin order set and titration algorithm in the inpatient setting. Hosp Pract (1995). 2016;44(5):260–5.CrossRef
35.
Fischer KF, Lees JA, Newman JH. Hypoglycemia in hospitalized patients. Causes and outcomes. N Engl J Med. 1986;315(20):1245–50.CrossRefPubMed
36.
Matyka K, Evans M, Lomas J, Cranston I, Macdonald I, Amiel SA. Altered hierarchy of protective responses against severe hypoglycemia in normal aging in healthy men. Diabetes Care. 1997;20(2):135–41.CrossRefPubMed
37.
Moen MF, Zhan M, Hsu VD, Walker LD, Einhorn LM, Seliger SL, et al. Frequency of hypoglycemia and its significance in chronic kidney disease. Clin J Am Soc Nephrol. 2009;4(6):1121–7.CrossRefPubMedPubMedCentral
38.
Gianchandani RY, Neupane S, Iyengar JJ, Heung M. Pathophysiology and management of hypoglycemia in end stage renal disease patients—a review. Endocr Pract. 2016;
39.
Arem R. Hypoglycemia associated with renal failure. Endocrinol Metab Clin N Am. 1989;18(1):103–21.
40.
Mak RH. Impact of end-stage renal disease and dialysis on glycemic control. Semin Dial. 2000;13(1):4–8.CrossRefPubMed
41.
42.
Hellman R. A systems approach to reducing errors in insulin therapy in the inpatient setting. Endocr Pract. 2004;10(Suppl 2):100–8.CrossRefPubMed
43.
Elliott MB, Schafers SJ, McGill JB, Tobin GS. Prediction and prevention of treatment-related inpatient hypoglycemia. J Diabetes Sci Technol. 2012;6(2):302–9.CrossRefPubMedPubMedCentral
44.
Farrokhi F, Klindukhova O, Chandra P, Peng L, Smiley D, Newton C, et al. Risk factors for inpatient hypoglycemia during subcutaneous insulin therapy in non-critically ill patients with type 2 diabetes. J Diabetes Sci Technol. 2012;6(5):1022–9.CrossRefPubMedPubMedCentral
45.
Maynard G, Lee J, Phillips G, Fink E, Renvall M. Improved inpatient use of basal insulin, reduced hypoglycemia, and improved glycemic control: effect of structured subcutaneous insulin orders and an insulin management algorithm. J Hosp Med. 2009;4(1):3–15.CrossRefPubMed
46.
•• Cobaugh DJ, Maynard G, Cooper L, Kienle PC, Vigersky R, Childers D, et al. Enhancing insulin-use safety in hospitals: practical recommendations from an ASHP Foundation expert consensus panel. Am J Health Syst Pharm. 2013;70(16):1404–13. This consensus paper provides practical recommendations to help ensure safe insulin use in hospitalized patients and minimize hypoglycemia.CrossRefPubMed
47.
Rubin DJ, Rybin D, Doros G, McDonnell ME. Weight-based, insulin dose-related hypoglycemia in hospitalized patients with diabetes. Diabetes Care. 2011;34(8):1723–8.CrossRefPubMedPubMedCentral
48.
Schafers S, Naunheim R, Vijayan A, Tobin G. Incidence of hypoglycemia following insulin-based acute stabilization of hyperkalemia treatment. J Hosp Med. 2012;7(3):239–42.CrossRefPubMed
49.
Curll M, Dinardo M, Noschese M, Korytkowski MT. Menu selection, glycaemic control and satisfaction with standard and patient-controlled consistent carbohydrate meal plans in hospitalised patients with diabetes. Qual Saf Health Care. 2010;19(4):355–9.CrossRefPubMed
50.
Boucher JL, Swift CS, Franz MJ, Kulkarni K, Schafer RG, Pritchett E, et al. Inpatient management of diabetes and hyperglycemia: implications for nutrition practice and the food and nutrition professional. J Am Diet Assoc. 2007;107(1):105–11.CrossRefPubMed
51.
Swift C. Nutrition therapy for the hospitalized and long-term care patient with diabetes. In: Franz M, Evert, A, editor. American Diabetes Association Guide to Nutrition Therapy for Diabetes. 2nd ed. Alexandria 2012. p. 229–45.
52.
53.
Umpierrez GE, Hellman R, Korytkowski MT, Kosiborod M, Maynard GA, Montori VM, et al. Management of hyperglycemia in hospitalized patients in non-critical care setting: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2012;97(1):16–38.CrossRefPubMed
54.
55.
Engle M, Ferguson A, Fields W. A journey to improved inpatient glycemic control by redesigning meal delivery and insulin administration. Clin Nurse Spec. 2016;30(2):117–24.CrossRefPubMed
56.
57.
Kilpatrick CR, Elliott MB, Pratt E, Schafers SJ, Blackburn MC, Heard K, et al. Prevention of inpatient hypoglycemia with a real-time informatics alert. J Hosp Med. 2014;9(10):621–6.CrossRefPubMed
58.
Flory JH, Aleman JO, Furst J, Seley JJ. Basal insulin use in the non-critical care setting: is fasting hypoglycemia inevitable or preventable? J Diabetes Sci Technol. 2014;8(2):427–8.CrossRefPubMedPubMedCentral
59.
Mathioudakis N, Everett E, Golden SH. Prevention and management of insulin-associated hypoglycemia in hospitalized patients. Endocr Pract. 2016;22(8):959–69.CrossRefPubMed
60.
HK GSJ, Lipska KJ, Je B, Lin Z, Inzucchi SE. Blood glucose trends and prediction of severe hypoglycemia in hospitalized patients. San Diego: American Diabetes Association; 2011.
61.
Lee SY, Askin G, McDonnell ME, Arnold LM, Alexanian SM. Hypoglycemia rates after restriction of high-dose glargine in hospitalized patients. Endocr Pract. 2016;22(12):1393–400.CrossRefPubMed
62.
Maynard G, Stein J. Designing and implementing effective venous thromboembolism prevention protocols: lessons from collaborative efforts. J Thromb Thrombolysis. 2010;29(2):159–66.CrossRefPubMed
63.
Maynard GA, Morris TA, Jenkins IH, Stone S, Lee J, Renvall M, et al. Optimizing prevention of hospital-acquired venous thromboembolism (VTE): prospective validation of a VTE risk assessment model. J Hosp Med. 2010;5(1):10–8.PubMed
64.
65.
Mendez CE, Ata A, Rourke JM, Stain SC, Umpierrez G. Daily inpatient glycemic survey (dings): a process to remotely identify and assist in the management of hospitalized patients with diabetes and hyperglycemia. Endocr Pract. 2015;21(8):927–35.CrossRefPubMed
66.
Rushakoff R, Sullivan M, MacMaster H, editors. The virtual inpatient glucose management service: improving glucose control and decreasing therapeutic inertia. San Francisco: The American Diabetes Association Scientific Sessions; 2014.
67.
Chapman JL, Lucas R, Lee J, Grimes SS, Porter AM, Bussey A. Implementation of inpatient blood glucose monitoring by clinical pharmacists. Am J Health Syst Pharm. 2013;70(17):1480–1.CrossRefPubMed
68.
Coats A, Marshall D. Inpatient hypoglycaemia: a study of nursing management. Nurs Prax N Z. 2013;29(2):15–24.PubMed
69.
Maynard G, Huynh M, Renvall M. Iatrogenic inpatient hypoglycemia: risk factors, treatment, and prevention analysis of current practice at an academic medical center with implications for improvement efforts. Diabetes Spectr. 2008;21(4):241–7.CrossRef
70.
71.
De Alwis DT, Varadarajan S, Lim K. Notifying a doctor of a first hypoglycaemic episode is associated with a lower rate of recurrence among inpatients with diabetes. Med J Aust. 2014;200(2):79.CrossRefPubMed
72.
Ellis R. Hypoglycaemia monitoring in a medical receiving ward. BMJ Qual Improv Rep. 2015;4(1)
73.
MacEwen AW, Carty DM, McConnachie A, McKay GA, Boyle JG. A “diabetes acute care day” for medical students increases their knowledge and confidence of diabetes care: a pilot study. BMC Med Educ. 2016;16:88.CrossRefPubMedPubMedCentral
74.
Tamler R, Dunn AS, Green DE, Skamagas M, Breen TL, Looker HC, et al. Effect of online diabetes training for hospitalists on inpatient glycaemia. Diabet Med. 2013;30(8):994–8.CrossRefPubMed
75.
Tamler R, Green DE, Skamagas M, Breen TL, Lu K, Looker HC, et al. Durability of the effect of online diabetes training for medical residents on knowledge, confidence, and inpatient glycemia. J Diabetes. 2012;4(3):281–90.CrossRefPubMed
76.
Tamler R, Green DE, Skamagas M, Breen TL, Looker HC, LeRoith D. Effect of case-based training for medical residents on confidence, knowledge, and management of inpatient glycemia. Postgrad Med. 2011;123(4):99–106.CrossRefPubMed
77.
Wesorick DH, Grunawalt J, Kuhn L, Rogers MA, Gianchandani R. Effects of an educational program and a standardized insulin order form on glycemic outcomes in non-critically ill hospitalized patients. J Hosp Med. 2010;5(8):438–45.CrossRefPubMed
78.
Selig PM, Popek V, Peebles KM. Minimizing hypoglycemia in the wake of a tight glycemic control protocol in hospitalized patients. J Nurs Care Qual. 2010;25(3):255–60.CrossRefPubMed
Metadata
Title
How Low Can You Go? Reducing Rates of Hypoglycemia in the Non-critical Care Hospital Setting
Authors
Kristen Kulasa
Patricia Juang
Publication date
01-09-2017
Publisher
Springer US
Published in
Current Diabetes Reports / Issue 9/2017
Print ISSN: 1534-4827
Electronic ISSN: 1539-0829
DOI
https://doi.org/10.1007/s11892-017-0902-3

Other articles of this Issue 9/2017

Current Diabetes Reports 9/2017 Go to the issue

Health Care Delivery Systems and Implementation in Diabetes (ME McDonnell and AR Sadhu, Section Editors)

Process-Based Treatment of Diabetes in Kaiser Permanente Southern California: How to Make Diabetes Care “Complete”

Macrovascular Complications in Diabetes (VR Aroda and A Getaneh, Section Editors)

Cardiovascular Outcome Trial Update in Diabetes: New Evidence, Remaining Questions

Immunology, Transplantation, and Regenerative Medicine (L Piemonti and V Sordi, Section Editors)

Immunological Issues After Stem Cell-Based β Cell Replacement

Immunology, Transplantation, and Regenerative Medicine (L Piemonti and V Sordi, Section Editors)

T Cell Populations and Functions Are Altered in Human Obesity and Type 2 Diabetes

Pediatric Type 2 and Monogenic Diabetes (PS Zeitler, Section Editor)

Use of Continuous Glucose Monitoring in Youth-Onset Type 2 Diabetes

Macrovascular Complications in Diabetes (VR Aroda and A Getaneh, Section Editors)

Can Cardiovascular Epidemiology and Clinical Trials Close the Risk Management Gap Between Diabetes and Prediabetes?
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits